Filing Flows › Intelligent Bio Solutions (INBS) › Recalls, complaints & regulation

Intelligent Bio Solutions (INBS): clinical trials

Intelligent Bio Solutions (INBS) beyond its filings: 2 active clinical trials.

Intelligent Bio Solutions' latest quarter

Intelligent Bio Solutions, Q4 FY26: revenue $1.1M (+36% year over year), operating margin -346.4%, net loss $3.9M, operating cash flow −$3.2M. The chart follows the revenue to costs, profit and cash.

Questions

How many clinical trials does Intelligent Bio Solutions have?

2 active studies on ClinicalTrials.gov, 0 in phase 3.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.